You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MEK162

Showing 26 - 50 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Oxford, United Kingdom
    Oxford University Hospital NHS Trust
Jun 14, 2021

Recurrent Melanoma, Stage IV Melanoma Trial in Los Angeles (Raf kinase inhibitor LGX818, binimetinib, laboratory biomarker

Withdrawn
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Raf kinase inhibitor LGX818
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Jul 23, 2020

Solid Tumor, Solid Tumor Trial in Worldwide (BEZ235 + MEK162)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Solid Tumor
  • BEZ235 + MEK162
  • Boston, Massachusetts
  • +5 more
Oct 7, 2020

Uveal Melanoma Trial in Worldwide (AEB071, MEK162)

Terminated
Has Results
  • Uveal Melanoma
  • Boston, Massachusetts
  • +6 more
Sep 14, 2020

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (MEK162, MEK inhibitor; oral,

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • MEK162, MEK inhibitor; oral
  • Paclitaxel, mitotic inhibitor; intravenous
  • Scottsdale, Arizona
  • +3 more
Sep 9, 2020

Melanoma Trial in Worldwide (LGX818, MEK162, LEE011)

Active, not recruiting
  • Melanoma
  • Los Angeles, California
  • +31 more
Jun 11, 2021

Solid Tumor Trial in United States (PF-07284892, lorlatinib, binimetinib)

Recruiting
  • Solid Tumor
  • Orange, California
  • +6 more
Feb 15, 2022

Advanced NSCLC, KRAS Gene Mutation, Lung Cancer Trial in Switzerland (Binimetinib, Pemetrexed, Cisplatin)

Completed
  • Advanced Non-small Cell Lung Cancer
  • +2 more
  • Basel, Switzerland
  • +3 more
Jul 13, 2021

Advanced Solid Tumors Trial in Worldwide (MEK162 + RAF265)

Completed
  • Advanced Solid Tumors
  • MEK162 + RAF265
  • Tampa, Florida
  • +7 more
Sep 28, 2020

Advanced Solid Tumors, Selected Solid Tumors Trial in Worldwide (BKM120 + MEK162)

Completed
  • Advanced Solid Tumors
  • Selected Solid Tumors
  • BKM120 + MEK162
  • Boston, Massachusetts
  • +11 more
Sep 30, 2020

Locally Advanced or Metastatic NRAS Mutant Melanoma Trial in Worldwide (LEE011, MEK162)

Completed
Has Results
  • Locally Advanced or Metastatic NRAS Mutant Melanoma
  • San Francisco, California
  • +16 more
Nov 23, 2020

Advanced Solid Tumors, Advanced or Metastatic Biliary Cancer, Metastatic Colorectal Cancer Trial in United States (ARRY-438162

Completed
  • Advanced Solid Tumors
  • +2 more
  • ARRY-438162 (MEK162), MEK inhibitor; oral
  • Los Angeles, California
  • +9 more
Sep 14, 2020

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Los Angeles (Binimetinib, Docetaxel, Laboratory Biomarker

Withdrawn
  • Recurrent Non-Small Cell Lung Carcinoma
  • Stage IV Non-Small Cell Lung Cancer
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • (no location specified)
Dec 2, 2022

Melanoma, Colorectal Cancer, Non-Small-Cell Lung Cancer Trial in Springdale, Nashville (PF-07799933, binimetinib, cetuximab)

Recruiting
  • Melanoma
  • +4 more
  • Fayetteville, Arkansas
  • +23 more
Jan 19, 2023

Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)

Terminated
Has Results
  • Pancreatic Cancer
  • Fayetteville, Arkansas
  • +17 more
Dec 28, 2021

NSCLC Trial in China, Taiwan (Encorafenib, Binimetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Beijing, China
  • +35 more
Jun 29, 2022

Leukemia Trial in Houston (MEK-162, Nilotinib, Questionnaires)

Terminated
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 10, 2020

Biliary Tract Cancer Trial in Seoul (MEK162+capecitabine)

Completed
  • Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 27, 2019

Solid Tumor and Hematologic Malignancies Trial in United States (MEK162)

Completed
Has Results
  • Solid Tumor and Hematologic Malignancies
  • MEK162
  • Mobile, Alabama
  • +67 more
Feb 2, 2021

Melanoma of Unknown Primary, Metastatic Malignant Tumor in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Melanoma of Unknown Primary
  • +5 more
  • (no location specified)
Feb 13, 2020

Metastatic or Unresectable Cutaneous Melanoma Trial in Worldwide (MEK162, Dacarbazine)

Completed
Has Results
  • Metastatic or Unresectable Cutaneous Melanoma
  • Fayetteville, Arkansas
  • +228 more
Mar 18, 2021

Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Binimetinib Oral Tablet

Not yet recruiting
  • Adamantinous Craniopharyngioma
  • Recurrent Adamantinomatous Craniopharyngioma
  • Binimetinib Oral Tablet [Mektovi]
  • Aurora, Colorado
  • +17 more
Nov 28, 2022

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (other, drug, procedure)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • cytology specimen collection procedure
  • +4 more
  • Scottsdale, Arizona
  • +7 more
Dec 16, 2019